TScan Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
TScan Therapeutics Inc
CIK #0001783328
EDGAR Form CIK 2011 - 2026
10-K [0001783328]
10-Q [0001783328]
3 [0001783328]
4 [0001783328]
8-K [0001783328]
D [0001783328]
SC 13D [0001783328]
SC 13G [0001783328]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc TScan Therapeutics Inc [2024-11-08]
BlackRock Inc TScan Therapeutics Inc [2024-10-21]
Cormorant Asset Management LP TScan Therapeutics Inc [2024-04-29]
Adage Capital Partners GP LLC TScan Therapeutics Inc [2023-06-12]
Biotechnology Value Fund L P TScan Therapeutics Inc [2023-06-05]
EcoR1 Capital LLC TScan Therapeutics Inc [2023-06-05]
Lynx1 Capital Management LP TScan Therapeutics Inc [2023-06-02]
K2 Healthventures Equity Trust LLC TScan Therapeutics Inc [2022-09-30]
Deer IX & Co Ltd TScan Therapeutics Inc [2022-02-14]
Hillhouse Investment Management Ltd TScan Therapeutics Inc [2022-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Klencke Barbara
TScan Therapeutics Inc
Nicholson Garry A
Gruia Gabriela
Dorton Katina
Woods Keith
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Zdraveski Zoran
Louis Chrystal
Amello Jason
MacBeath Gavin
Dworak Leiden
Nichols Weston
Lynx1 Capital Management LP
Barberich Timothy J
Silver Brian M
Barton Debora
EcoR1 Capital LLC
Southwell David P
Desmarais William
Harel Ittai
Westphal Christoph H
Biggar Stephen R
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 350,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 1,165,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 100,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 420,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2026-01-20 Grant 350,000 $0.00
TScan Therapeutics Inc TCRX
Common Stock
2025-12-23 Buy 6,232 $0.90 5,609
TScan Therapeutics Inc TCRX
Common Stock
2025-12-22 Buy 75,500 $0.90 67,950
TScan Therapeutics Inc TCRX
"Common stock, $0.0001 par value per share (""Common Stock"")"
2025-12-19 Buy 80,069 $0.90 72,062
TScan Therapeutics Inc TCRX
Non- Qualified Stock Option (right to buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Non- Qualified Stock Option (right to buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-06-30 Grant 67,000 $0.00
TScan Therapeutics Inc TCRX
Common Stock
2025-05-20 Buy 1,200,000 $1.20 1,440,000
TScan Therapeutics Inc TCRX
"Common stock, $0.0001 par value per share (""Common Stock"")"
2025-05-19 Buy 1,388,794 $1.20 1,666,553
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 270,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 250,000 $0.00
TScan Therapeutics Inc TCRX
Stock Option (Right to Buy) · derivative
2025-01-03 Grant 800,000 $0.00
showing 20 of 135 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com